Maintaining adequate vitamin D levels during early middle age may serve as a protective shield against long-term cognitive decline. A study published April 1 in the journalNeurology Open Accesssuggests that individuals with higher levels of the vitamin in their 30s and 40s show significantly lower levels of tau protein in their brains 16 years later.
Researchers from the University of Galway tracked 793 adults who were, on average, 39 years old and cognitively healthy at the start of the study. After measuring initial blood vitamin D levels, the team conducted brain scans more than a decade later to track markers associated with Alzheimer’s disease, specifically tau and amyloid beta proteins.
The long-term impact of midlife nutrition
The data revealed a distinct correlation: participants who maintained vitamin D levels above 30 nanograms per milliliter (ng/mL) during their midlife years had lower accumulations of tau protein. Tau is a protein that forms tangles in the brain, which are widely recognized as a primary indicator of neurodegenerative diseases.
"These results suggest that higher vitamin D levels in midlife may offer protection against developing these tau deposits in the brain," said study author Dr. Martin David Mulligan. "Low vitamin D levels could potentially be a risk factor that could be modified and treated to reduce the risk of dementia."
Despite the findings regarding tau, the study did not find a similar link between vitamin D levels and amyloid beta protein, another significant biomarker for Alzheimer's. Additionally, the researchers noted that the study demonstrates an association rather than direct causation. While the link is promising, it does not confirm that vitamin D supplements alone prevent dementia.
At the start of the study, 34% of participants were classified as having low vitamin D levels, yet only 5% reported using supplements. This indicates a widespread deficiency during a critical window for neurological health.
Dr. Mulligan emphasized the importance of timing in preventative health. "Mid-life is a time where risk factor modification can have a greater impact," he noted.
The study identified a key limitation: vitamin D levels were recorded as a single measurement rather than a longitudinal trend. Researchers stressed that further, more comprehensive studies are required to confirm these findings and to determine if clinical intervention can genuinely alter the course of long-term brain health. The research was supported by the National Institute on Aging and the National Institute of Neurological Disorders and Stroke, among other international health organizations.
